2016 Joint Health SMART Act Presentation, Department of Health Care Policy and Financing
Presented to the Joint Health Committees.
First Regular Session | 75th General Assembly
Colorado General AssemblyPresented to the Joint Health Committees.
Presented to the Joint Health Committee.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee.
Colorado receives annual payments from tobacco manufacturers as part of the Tobacco Master Settlement Agreement. In April 2016, the state received $92.3 million. This memorandum presents the distribution of the 2016 payment and forecasts payments through 2019.
This memorandum provides an overview of the recovery of damages for loss of use by rental vehicle companies and various state laws that prohibit or limit the recovery of these damages.
This issue brief provides an overview of state laws related to insurance guaranty funds. Insurance guaranty funds are designed to avoid excessive delays in payment and financial losses to insurance claimants or policyholders because of the insolvency of an insurer.
The Legislative Council Staff's Health Care Resource Book is intended to serve as a reference guide for information on some of Colorado's major health care issues and programs. The book is divided into two sections.
The first section covers health care spending; private health insurance...
This memorandum provides an overview of the 2017 membership of the Opioid and Other Substance Use Disorders Interim Study Committee, the origin and charge of the committee, bill request deadlines and procedures, and information regarding committee staff and the committee website. Information is...
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.